DS
SANA icon

DRW Securities’s Sana Biotechnology SANA Stock Holding History

DRW Securities’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$231K Buy
66,249
+53,866
+435% +$174K 0.01% 740
2026
Q1 		$35.7K Buy
+12,383
New +$48.8K ﹤0.01% 1209

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

DRW Securities's SANA Position: Q2 2026 in Review

DRW Securities increased its Sana Biotechnology (SANA) stake by 435% in Q2 2026, buying an estimated $174K and bringing the position to 66,249 shares worth $231K. The position accounts for 0.01% of the portfolio, ranked #740.

DRW Securities first reported a position in SANA in Q1 2026 and has held it in 2 quarters since. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • DRW Securities held 66,249 shares of Sana Biotechnology worth $231K as of Q2 2026.
  • DRW Securities bought 53,866 Sana Biotechnology shares in Q2 2026, an estimated $174K.
  • Sana Biotechnology made up 0.01% of DRW Securities's portfolio in Q2 2026, its #740 holding.
  • DRW Securities first reported a position in Sana Biotechnology in Q1 2026 and has held it in 2 quarters since.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.